The growth of the airway clearance systems market is driven by the rise in respiratory disorders across the globe.
PORTLAND, OREGON, USA, September 8, 2022 /EINPresswire.com/ — According to a new report published by Allied Market Research, titled “Airway Clearance System Market By Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2018-2026”, the Airway Clearance System market size is expected to reach USD 922 million by 2026, registering a CAGR of 4.7% from 2019 to 2026, in terms of value.
Airway clearance is a therapy used to loosen mucus in patients with respiratory conditions such as COPD, asthma, cystic fibrosis and others. The major increase in the incidence of all-inclusive respiratory disorders has led to an increased demand for these devices. For example, according to the Global Initiative for Asthma (GINA), approximately 300 million people worldwide suffer from asthma each year. Additionally, COPD, was the 3rd leading cause of death, resulted in the death of 3 million people in 2017. Additionally, to treat these disorders, a variety of airway clearance systems have been introduced in the market, such as Positive Expiratory Pressure (PEP), High Frequency Chest Wall Oscillation (HFCWO). However, Positive Expiratory Pressure (PEP) is the most effective treatment option compared to other methods.
Download a sample report (get full information in PDF format – over 200 pages):
♦ Major Key Players –
Comprehensive competitive analysis and profiles of major market players such as Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy Inc Hill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips NV (Philips), Monaghan Medical Corporation, Inc., and PARI GmbH, Thayer Medical. are provided in this report.
• The Covid-19 pandemic and subsequent containment affected several manufacturing industries.
• Prolonged lockdown disrupted supply chain and increased commodity prices.
• However, as the world recovers from the pandemic, the market is believed to be getting back on track.
The significant increase in the prevalence of cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD) across the globe is the major driver for the growth of the airway clearance systems market. For example, US Cystic Fibrosis Foundation, more than 30,000 people live with cystic fibrosis in the country. In addition, the major factors driving the growth of the airway clearance systems market are the rising concerns over respiratory diseases, such as asthma and emphysema, and the rising incidence of respiratory diseases caused by cigarette smoking. The growth of the airway clearance systems market would be boosted owing to the increase in healthcare expenditures, growth in the use of home care devices in the healthcare sector and rapid adoption of advanced medical solutions. Currently, most medical professionals and lung disease experts prefer a combination of a drug and a device, due to its quick and effective result. However, factors such as the high cost correlated with airway clearance systems and side effects due to their overuse may hamper the growth of the airway clearance systems market.
Technological advancements in airway clearance such as provision of minimally invasive treatments, increased awareness among individuals for self-grooming are the major factors driving the growth of the airway clearance market. Additionally, rising disposable incomes in developing economies such as China and India are further contributing to the growth of the market.
Find out before you buy:
CHAPTER 1 INTRODUCTION
1.1. Description of the report
1.2. Main benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and templates
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Main results of the study
2.2. CXO point of view
By type, positive expiratory phase (PEP) accounted for the majority of the respiratory system market share in 2018 and is expected to show significant growth in the near future, owing to and it is the most commonly aircraft authorization used. system. used for the treatment of cystic fibrosis. However, the segment of flexible PEP devices is expected to grow at the fastest rate during the forecast period.
By application, the bronchiectasis segment dominates the respiratory system market in 2018 and is expected to maintain its dominance during the forecast period. This is due to the increase of this disease all over the world. For example, according to the British Lung Foundation, around 210,000 people in the UK were living with bronchiectasis in 2016.
Analyst Review –
The airway clearance systems market is expected to grow steadily in the future, owing to its increasing use in patients suffering from bronchiectasis. However, the high cost of these systems and the stringent reimbursement scenario is expected to hamper the market growth in the future. Additionally, North America is dominating the market in 2018, owing to the sharp increase in the prevalence of respiratory disorders, patient awareness and availability of these devices. Asia-Pacific is expected to witness the fastest growth rate in the near future, owing to the sharp increase in the prevalence of COPD and asthma.
Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.